Hypercholesterolemia vs Genesis Study
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
Hypercholesterolemia
Read full descriptionHide full description
@Point of Careβ’ with Cognitive AI is a clinical decision-making mobile platform. Hypercholesterolemia @Point of Careβ’ provides a streamlined clinical decision support tool for clinicians to obtain content when it is neededβenabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Careβ’ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Hypercholesterolemia @Point of Careβ’ is designed to: β’ Support discovery and practice change β’ Provide relevant, evidence-based disease-specific medical content β’ Improve patient outcomes at the point of care Features: β’ Continually updated Hypercholesterolemia content β’ Topics in diagnosis, treatment, and care management developed with expert physician authors β’ Case studies, videos, and interviews β’ Access to actionable patient-recorded data β’ Detailed reference list with access to original sources β’ Continuing medical education credit (CME/CE) β’ Surveys and peer polling β’ Patient education resources to share with patients
Genesis Study
Read full descriptionHide full description
A 12-month randomised, double-blind, controlled, international multicentre trial comparing changes in cigarette consumption after switching to high or low nicotine strength e-cigarettes in smokers with Schizophrenia spectrum disorders. This will be a multicenter, 12-months prospective trial, utilizing a randomized, double-blind, 2-arm parallel, switching design to compare effectiveness, tolerability, acceptability, and pattern of use between high (JUUL 5% nicotine) and low nicotine strength devices (JUUL 1.5% nicotine) in adult smokers with schizophrenia spectrum disorders. The study will take place at 5 sites: 1 in the UK (London) and possibly 4 in Italy. DISCLAIMER : To seek a doctorβs advice in addition to using this app and before making any medical decisions. We are using HealthKit to get step count to display on Health Dairy screen and graph on Report screen. We also send daily step count to server with questionary for study purpose.
Screenshots
Verdict
Hypercholesterolemia and Genesis Study are too close to call on the numbers: across 6 compared parameters β price, update cadence, ads and in-app purchases among them β neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Hypercholesterolemia ships an update every 2 months, Genesis Study every 6 weeks. The most recent releases landed on October 26, 2026 and October 27, 2026 respectively.
| Parameter | Hypercholesterolemia | Genesis Study |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 2 months | Every 6 weeks β better |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod β better | iPhone, iPod |
| Requires iOS | 14.0 | 13.0 β better |
| Further details β not scored | ||
| Size | 21 MB | 33 MB |
| Age rating | 12+ | 17+ |
| Developer | @Point of Care | Eclat srl |
In-app purchases
Hypercholesterolemia
No in-app purchases
Genesis Study
No in-app purchases
Questions
Is Hypercholesterolemia free?
Is Genesis Study free?
Do Hypercholesterolemia or Genesis Study have ads?
Which is updated more often, Hypercholesterolemia or Genesis Study?
Other comparisons















